Balanced news tone
News Sentiment
VCYT sentiment intelligence
Veracyte Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-0.2% over one week, +20.4% over four weeks, trend active, and materially above fair value.
A Look at Veracyte Inc (VCYT) After 5.1% Gain -- GF Value $38.30 vs Price $59.51
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Enterprise value to EBITDA forward of Veracyte, Inc. – NASDAQ:VCYT
This article provides a brief snapshot of the "Enterprise value to EBITDA forward" for Veracyte, Inc. (NASDAQ: VCYT) according to TradingView. It indicates that the market was closed at the time the data was viewed, with no trades recorded. The content is primarily a data point w
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 18:10
- Source
- TradingView
Veracyte (VCYT) On Pipeline Momentum And A Valuation Question
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 09:20
- Source
- simplywall.st
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 07:00
- Source
- The Motley Fool
Veracyte, Inc. Actuals & Estimates (NASDAQ:VCYT)
This article provides an overview of Veracyte, Inc. (NASDAQ: VCYT) stock, including its current price, historical performance, and analyst forecasts. It also details the company's financial actuals and estimates, such as recent earnings, revenue, net income, and market capitaliza
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 27 Jun 2026 06:10
- Source
- TradingView
Veracyte, Inc. Actuals & Estimates (MUN:12V)
This article provides an overview of Veracyte, Inc. (MUN:12V) financials, analyst estimates, and key company data. It includes details on past earnings performance, revenue, EBITDA, and analyst price targets, alongside upcoming earnings report dates. The article also addresses fr
- Tone
- Positive 63/100
- Event
- Earnings
- Published
- 27 Jun 2026 05:39
- Source
- TradingView
Veracyte, Inc. Actuals & Estimates (DUS:12V)
This article provides an overview of Veracyte, Inc. (12V) stock details, including financial actuals, analyst estimates, and key performance indicators. It covers income statements, balance sheets, cash flow, and valuation metrics, along with answers to frequently asked questions
- Tone
- Positive 70/100
- Event
- Analyst action
- Published
- 27 Jun 2026 03:11
- Source
- TradingView
Veracyte Inc (VCYT) Shares Surge 3.1% -- What GF Score of 75 Tell Investors
Veracyte Inc (VCYT) shares surged 3.1% to $58.59 on June 25, 2026, marking a 30.0% appreciation over the last month. Despite a strong GF Score of 75/100, indicating above-average performance, the stock is considered "Significantly Overvalued" with a current price considerably abo
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 26 Jun 2026 06:10
- Source
- GuruFocus
VCYT Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for Veracyte, Inc. (VCYT) stock, based on analyst ratings and current market performance. It details the company's financial metrics, including recent earnings and revenue, and answers frequently asked questions about its stock pe
- Tone
- Positive 76/100
- Event
- Earnings
- Published
- 26 Jun 2026 05:10
- Source
- TradingView
Veracyte stock hits 52-week high at 55.32 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Investing.com
Veracyte (VCYT) director logs 3,729-share Rule 10b5-1 stock sale
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
This Top Stock Has Surged. CEO Explains Key To Veracyte's Success.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 20:08
- Source
- Investor's Business Daily
[144] VERACYTE, INC. SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Stock Titan
Veracyte CEO Explains How It's Blazing A Trail In Cancer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Investor's Business Daily
High Growth Momentum Breakout Setup: Veracyte Inc (NASDAQ:VCYT)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- ChartMill
Director at Veracyte (VCYT) receives grant of 5,272 restricted stock units
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Veracyte (VCYT) director Jens Holstein awarded 5,272 restricted stock units
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Market source
Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Jun 2026 07:00
- Source
- Market source
Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Business Wire
Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- TradingView
Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- Market source
Shareholders Will Be Pleased With The Quality of Veracyte's (NASDAQ:VCYT) Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
Veracyte (VCYT) Q1 2026 Earnings: Revenue Up 21%, EPS Quadruples, Shares Climb 23% - News and Statistics
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- IndexBox
Veracyte (VCYT) Margin Expansion And 166% Earnings Growth Test Premium Valuation Narratives
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- simplywall.st
Veracyte, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Wall Street Analysts Think Veracyte (VCYT) Could Surge 39.16%: Read This Before Placing a Bet
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Market source
Veracyte (VCYT) Beats Q1 Earnings and Revenue Estimates
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- Market source
Is Veracyte Stock the Right Pick for Your Portfolio Now?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- Market source
Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Mar 2026 07:00
- Source
- Market source
Veracyte Taps Kevin Haas To Guide AI Push And Undervalued Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Mar 2026 07:00
- Source
- simplywall.st